AI assistant
BIO-TECHNE Corp — Director's Dealing 2015
Aug 11, 2015
30718_dirs_2015-08-11_ca09e977-1be1-4a49-8c51-7a9005d07a25.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2015-08-07
Reporting Person: Gavin Robert M. (Senior V.P. Protein Platforms)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-08-07 | Stock Option (Right to Buy) | $108.49 | A | 12500 | Acquired | 2022-08-07 | Common Stock (12500) | Direct |
| 2015-08-07 | Stock Option (Right to Buy) | $108.49 | A | 6250 | Acquired | 2022-08-07 | Common Stock (6250) | Direct |
| 2015-08-07 | Restricted Stock Units | $ | A | 1000 | Acquired | Common Stock (1000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $93.32 | 2021-07-31 | Common Stock (10000) | 10000 | Direct |
| Stock Option (Right to Buy) | $93.32 | 2021-07-31 | Common Stock (50000) | 50000 | Direct |
| Stock Option (Right to Buy) | $90.25 | 2021-11-30 | Common Stock (5000) | 5000 | Direct |
| Restricted Stock Units | $ | Common Stock (5000) | 5000 | Direct |
Footnotes
F1: 2,500 shares vest on each of 7/31/15, 7/31/16, 7/31/17 and 7/31/18.
F2: The options vest if certain performance goals are achieved for calendar 2016.
F3: 1,500 shares vest on each of 12/1/15, 12/1/16, 12/1/17 and 12/1/18.
F4: Vests in full or in part if certain performance goals are achieved for calendar 2016 (previously reported in Table I).
F5: 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
F6: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F7: Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.